Can a lactating mother safely use systemic, inhaled, or topical steroids while breastfeeding, and what dosing and timing precautions are recommended?

Steroids and Breastfeeding

Systemic corticosteroids at doses of prednisone <20 mg daily (or equivalent non-fluorinated glucocorticoid) are compatible with breastfeeding without any special precautions, while doses ≥20 mg daily require either delaying breastfeeding or discarding breast milk for 4 hours after administration. 1

Systemic Corticosteroids

Low-Dose Systemic Steroids (<20 mg prednisone daily)

• Prednisone <20 mg daily or equivalent non-fluorinated glucocorticoids can be used safely during breastfeeding without interruption. 1
• The American College of Rheumatology (ACR) recommends these doses as compatible with breastfeeding based on minimal infant exposure. 1

High-Dose Systemic Steroids (≥20 mg prednisone daily)

• For doses ≥20 mg prednisone daily, mothers should either delay breastfeeding or discard breast milk accumulated in the 4 hours following glucocorticoid administration. 1
• This timing recommendation is based on peak drug concentrations in breast milk occurring within the first 4 hours post-dose. 1
• After the 4-hour window, breastfeeding can resume safely. 1

Inhaled Corticosteroids

Inhaled corticosteroids, specifically budesonide at maintenance doses of 200-400 mcg twice daily, result in negligible systemic exposure to breastfed infants and are safe to continue during breastfeeding. 2

Evidence for Inhaled Budesonide

• Budesonide concentrations in breast milk are consistently lower than maternal plasma levels, with a mean milk/plasma ratio of 0.46. 2
• The estimated daily infant dose is only 0.3% of the maternal dose for both 200 mcg and 400 mcg twice-daily dosing. 2
• Infant plasma concentrations were below the limit of quantification in all tested samples, confirming minimal systemic absorption. 2
• Inhaled and nasal treatments for asthma and allergic rhinitis are unlikely to affect breastfed infants. 3

Topical Corticosteroids

Topical corticosteroids applied to skin areas away from the breast are generally safe during breastfeeding, though specific safety data for dermatologic medications during lactation should be consulted. 4

• Topical medications have minimal systemic absorption, making them low-risk for breastfed infants. 4
• Avoid applying topical steroids directly to the nipple or areola to prevent direct infant ingestion. 4

Key Clinical Considerations

General Principles

• Women with rheumatic and musculoskeletal diseases should be encouraged to breastfeed if they desire and are able to do so. 1
• Disease control should be maintained with lactation-compatible medications rather than discontinuing breastfeeding. 1
• The relative infant dose (infant dose mg/kg/day divided by maternal dose mg/kg/day) of <10% is considered safe. 1

Common Pitfalls to Avoid

• Do not automatically discontinue breastfeeding based on package insert warnings, as these often reflect medicolegal caution rather than evidence-based risk. 3, 5
• Do not confuse fluorinated glucocorticoids (like dexamethasone) with non-fluorinated ones (like prednisone), as the recommendation specifically applies to non-fluorinated formulations. 1
• Do not advise routine 24-hour interruption of breastfeeding after any steroid dose, as this is not evidence-based and only applies to high-dose systemic steroids within a 4-hour window. 6

Timing Strategy for Medication Administration

• Administer medications immediately before the infant's longest sleep interval to minimize infant exposure during peak drug concentrations in breast milk. 3
• For high-dose systemic steroids, this timing strategy combined with the 4-hour milk discard window provides optimal safety. 1

Resource Recommendation

• Use LactMed (free online government-sponsored database) as an authoritative, current resource for medication safety information during lactation. 3
• This resource provides specific data on drug transfer into breast milk and infant safety profiles. 3